REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough leukemia: targeted therapy shows promise
Disease control Recruiting nowThis study tests a drug called inotuzumab ozogamicin in children and young adults (ages 1 to 21) whose B-cell acute lymphoblastic leukemia (B-ALL) has come back or stopped responding to treatment. The drug works like a smart bomb, attaching to a marker on leukemia cells and deliv…
Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New hope for tough leukemia: Triple-Drug combo trial opens
Disease control Recruiting nowThis early-phase trial tests a combination of three drugs (asparaginase, venetoclax, and blinatumomab) in adults aged 12-55 whose B-cell acute lymphoblastic leukemia has returned or not responded to prior treatment. The goal is to find a safe dose and see if the combo can help th…
Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New combo therapy offers hope for Hard-to-Treat leukemia
Disease control Recruiting nowThis study combines a targeted antibody-drug (inotuzumab ozogamicin) with low-intensity chemotherapy to treat acute lymphoblastic leukemia (ALL). It includes older adults (60+) with newly diagnosed ALL and younger adults (18-59) who are not fit for standard chemo, as well as pati…
Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
New Two-Pronged attack tested for tough blood cancer in older adults
Disease control Recruiting nowThis study is testing a combination of two targeted drugs, inotuzumab ozogamicin and blinatumomab, for adults with a specific type of acute lymphoblastic leukemia (ALL). It is for older adults newly diagnosed with this cancer or adults whose cancer has come back or hasn't respond…
Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 07, 2026 14:36 UTC